PRIMEBIOTICS LTD - Accounts

PRIMEBIOTICS LTD
Contents Page
For the Period 10 July 2024 to 31 July 2025

Statement of financial position	1
Notes to the financial statements	2

PRIMEBIOTICS LTD
Statement of Financial Position
As at 31 July 2025

	Notes	2025 £
Current assets
Cash at bank and in hand		100
Net current assets		100

Total assets less current liabilities		100
Net assets		100

Capital and reserves
Called up share capital	1	100
Shareholders' funds		100

For the period ended 31 July 2025 the company was entitled to exemption from audit under Section 480 of the Companies Act 2006 relating to dormant companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476.
The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The financial statements were approved by the director on 26 August 2025 and were signed by:

-------------------------------
Muhammad Wakas Akhtar Kayani
Director

1

PRIMEBIOTICS LTD
Notes to the Abridged Financial Statements
For the Period 10 July 2024 to 31 July 2025

General Information

PRIMEBIOTICS LTD is a private company, limited by shares, registered in England and Wales, registration number 15829915, registration address 238 Highgate Road, Sparkbrook, Birmingham, B12 8EA.

The presentation currency is £ sterling.

1.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.

The financial statements are prepared in sterling which is the functional currency of the company.

Taxation

Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted

2.

Share Capital

Allotted, called up and fully paid	2025 £
100 Class A shares of £1.00 each	100
	100

3.	Average number of employees Average number of employees during the period was 0.

2

Registered Number: 15829915
England and Wales
PRIMEBIOTICS LTD

Dormant Accounts

Period of accounts Start date: 10 July 2024 End date: 31 July 2025